Wharton´s Jelly Derived Mesenchymal Stromal Cell Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes
Clinical trial NCT03973827 · COMPLETED
Trial details
- NCT number
- NCT03973827
- Sponsor
- NextCell Pharma Ab
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-17
- Primary completion
- 2020-12-10
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.